Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.

AIDS (London, England) - 22 Dec 2000

Miller V, Sabin C, Hertogs K, Bloor S, Martinez-Picado J, D'Aquila R, Larder B, Lutz T, Gute P, Weidmann E, Rabenau H, Phillips A, Staszewski S

Abstract excerpt

OBJECTIVE: To analyse the immunological and virological effects of treatment interruptions in HIV-1-infected patients with treatment failure and multidrug-resistant virus. METHODS: Drug susceptibility was assessed using Antivirogram and genotypic analysis was based on population and clonal sequencing for 48 patients who had interrupted treatment (> or = 2 months). RESULTS: Treatment interruption resulted in viral...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Drug Therapy, Combination

Share to Reverse Transcriptase Inhibitors

Share to Salvage Therapy

Share to Treatment Failure

Share to Viral Load

Source

Identifiers

PMID: 11153667
DOI: 10.1097/00002030-200012220-00007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.PMID 11153667Read ↗

HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.Semantic proximity Read ↗

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.Semantic proximity Read ↗

Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.Semantic proximity Read ↗

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.Semantic proximity Read ↗

Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.Semantic proximity Read ↗

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response.Semantic proximity Read ↗

Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.Semantic proximity Read ↗

Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).Semantic proximity Read ↗

HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance.Semantic proximity Read ↗

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.Semantic proximity Read ↗

Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection.Semantic proximity Read ↗

Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.